Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Nurix Therapeutics, Inc.

NASDAQ: NRIX · Life Sciences · 11 alerts · CIK 1549595

Share price
$14.73Close, Nov 16
Market cap
$1.61B
Shares outstanding
109.25MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nurix Therapeutics, Inc. filings on SEC EDGAR ↗

6:22 AM ET 10-Q
Financial Results

Nurix Therapeutics Q3 2026 Results: Turns Profitable, Net Income $550M

Nurix Therapeutics reported a significant swing to profitability for the quarter ended August 31, 2026, with net income of $549.8 million compared to a net loss of $86.4 million in the prior year, primarily driven by $653.2 million in license revenue. The company's cash position strengthened significantly to $720.2 million, up from $247.0 million at the end of fiscal 2025.

Key figure
Net income $550M
6:20 AM ET 8-K
Financial Results

Nurix Therapeutics Financial Results

Nurix Therapeutics reported financial results for its fiscal third quarter ended August 31, 2026, highlighting a cash position of $1.1 billion following a $700 million upfront payment from its Roche collaboration. The company achieved several clinical milestones, including dosing the first patient in its Phase 3 DAYBreak CLL-306 trial and advancing its STAT6 degrader into Phase 1 with Sanofi.

Term
Q3 2026

“The third quarter marked an important transition for Nurix as we moved bexobrutideg into Phase 3 development in CLL and began executing a broader clinical strategy designed to realize its potential across lines of therapy in both oncology and auto-immune disease.”

Arthur T. Sands, M.D., Ph.D., president and chief executive officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.